Expert Interviews: Phenotypic Precision Medicine in Advanced Prostate Cancer
Andrew Armstrong, MD ScM FACP, is interviewed by Daniel Tennenbaum, MD on new research in phenotypic precision medicine.
Andrew Armstrong, MD ScM FACP, is interviewed by Daniel Tennenbaum, MD on the role of pain in prostate cancer.
Andrew Armstrong, MD ScM FACP, is interviewed by Daniel Tennenbaum, MD on the role of precision medicine in prostate cancer.
Evan Ya-Wen Yu, MD, talks about different types of precision medicine, the future of precision medicine, and more.
Evan Ya-Wen Yu, MD, discusses what precision medicine is, how patients were treated before precision medicine, and more.
Dr. Rettig explores the impact of precision medicine and the future of prostate cancer care.
Drs. Michael Morris and Akhil Saji discuss the future of PSMA-targeted therapies in advanced prostate cancer.
Drs. Michael Morris and Akhil Saji discuss the future of PSMA-targeted therapies in advanced prostate cancer.
Drs. George and Ambinder discuss precision medicine approaches in advanced prostate cancer, including genetic testing.
Drs. George and Ambinder discuss precision medicine approaches in APC and using somatic tumor markers to guide patient care.
Drs. Agarwal and Calais discuss the cost-effectiveness of PSMA-PET/CT versus conventional imaging.
Dr. Armstrong discussed the development of new precision medicine approaches and the challenges of precision medicine.
Dr. George discussed novel therapies that are shaping the way advanced prostate cancer is treated.
Dr. Calais discussed the impact of precision medicine on prostate oncology, advantages and challenges of PSMA PET and more.
GU Oncology Now sat down with Dr. Daniel Spratt, an expert in prostate cancer, to discuss phenotypic precision medicine.
Jacob Berchuck, MD, discusses clinical considerations for the management of androgen indifferent prostate cancer.
Jacob Berchuck, MD, discusses clinical considerations for the management of androgen indifferent prostate cancer.
Dr. Neeraj Agarwal discusses DNA damage repair gene mutations in paired primary and metastatic prostate cancer samples.
Dr. Iagaru discusses the latest updates in prostate cancer imaging using positron emission tomography.
Scott T. Tagawa, MD, Professor of Medicine and Urology, discusses upcoming therapies for prostate cancer treatment.
Advertisement
Advertisement
